Franklin M Berger Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

Franklin M Berger is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 476,897 shares of AVIR, which is worth approximately $1.46 Million. The most recent transaction as insider was on Jan 16, 2025, when has been sold 10,000 shares (Common Stock) at a price of $3.36 per share, resulting in proceeds of $33,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 477K

41.23% 3M change

38.73% 12M change

Total Value Held $1.46 Million

FRANKLIN M BERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 16 2025	SELL Open market or private purchase	$33,600 $3.36 p/Share	10,000 Reduced 2.05%	476,897 Common Stock
Jan 15 2025	SELL Open market or private purchase	$47,850 $3.19 p/Share	15,000 Reduced 3.11%	466,897 Common Stock
Dec 10 2024	SELL Open market or private sale	$1,024,877 $2.85 p/Share	359,606 Reduced 44.31%	451,897 Common Stock
Jun 16 2024	BUY Exercise of conversion of derivative security	-	33,150 Added 3.92%	811,503 Common Stock
Nov 14 2022	SELL Open market or private sale	$83,416 $5.16 p/Share	16,166 Reduced 2.03%	778,353 Common Stock
Nov 11 2022	SELL Open market or private sale	$131,325 $5.15 p/Share	25,500 Reduced 3.11%	794,519 Common Stock
Nov 03 2020	BUY Open market or private purchase	$999,984 $24.0 p/Share	41,666 Added 4.84%	820,019 Common Stock
Nov 03 2020	BUY Conversion of derivative security	-	759,606 Added 49.39%	778,353 Common Stock

Also insider at

EPIX

ESSA Pharma Inc. Healthcare

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

RAIN

Rain Therapeutics Inc. Healthcare

Director

BCEL

Atreca, Inc. Healthcare

Director

KZR

Kezar Life Sciences, Inc. Healthcare

FMB